BIOGEN INC. Long-term Debt and Lease Obligation
BIOGEN INC. (BIIB) had Long-term Debt and Lease Obligation of $0 as of 2017-12-31, per its 10-K filed 2018-02-01.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2018-02-01
- 2017-12-31: Long-term Debt and Lease Obligation $0.00.
- 2016-12-31: Long-term Debt and Lease Obligation $16.40M.
- 2015-12-31: Long-term Debt and Lease Obligation $18.10M.
- 2014-12-31: Long-term Debt and Lease Obligation $0.00.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-01 |
| 2016-12-31 | $16.40M 10-K · filed 2018-02-01 |
| 2015-12-31 | $18.10M 10-K · filed 2017-02-02 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |